Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
Tambone Reyes
M
M
Chair of hematology and chair of medical pathology, Institute of Clinical Medicine, University of Palermo, Italy.
Bonaccorso
R
R
Gebbia
V
V
Tinnirello
D
D
Di Salvo
V
V
Ciulla
A
A
Di Marco
P
P
Mansueto
S
S
Citarrella
P
P
D000368:Aged; D000369:Aged, 80 and over; D000754:Anemia, Refractory, with Excess of Blasts / Q000188:drug therapy; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine